Related Experiment Video
Updated: May 26, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
Published on: September 7, 2021
Pharmacological maintenance of protein homeostasis could postpone age-related disease
Silvestre Alavez1, Gordon J Lithgow
1Buck Institute for Research on Aging, Novato, CA 94945, USA. salavez@buckinstitute.org
Abstract:
Over the last 10 years, various screens of small molecules have been conducted to find long sought interventions in aging. Most of these studies were performed in invertebrates but the demonstration of pharmacological lifespan extension in the mouse has created considerable excitement. Since aging is a common risk factor for several chronic diseases, there is a reasonable expectation that some compounds capable of extending lifespan will be useful for preventing a range of age-related diseases. One of the potential targets is protein aggregation which is associated with several age-related diseases. Genetic studies have long indicated that protein homeostasis is a critical component of longevity but recently a series of chemicals have been identified in the nematode Caenorhabditis elegans that lead to the maintenance of the homeostatic network and extend lifespan. Herein we review these interventions in C. elegans and consider the potential of improving health by enhancing protein homeostasis.
Insights
Small molecules can extend lifespan and improve healthspan by enhancing protein homeostasis. Research in Caenorhabditis elegans shows these interventions may prevent age-related diseases.
Area of Science:
- Gerontology and molecular biology
- Investigating the biological mechanisms of aging and longevity
Background:
- Aging is a major risk factor for chronic diseases.
- Protein aggregation is linked to several age-related conditions.
- Maintaining protein homeostasis is crucial for longevity.
Purpose of the Study:
- Review small molecule interventions targeting aging.
- Focus on compounds enhancing protein homeostasis in C. elegans.
- Evaluate potential for preventing age-related diseases.
Main Methods:
- Analysis of published studies on small molecule screens for aging interventions.
- Review of research identifying chemicals that maintain protein homeostasis in C. elegans.
- Synthesis of findings on lifespan extension and healthspan improvement.
Main Results:
- Pharmacological lifespan extension demonstrated in mice.
- Several chemicals identified in C. elegans that enhance protein homeostasis and extend lifespan.
- These interventions show promise for improving healthspan.
Conclusions:
- Enhancing protein homeostasis is a viable strategy for promoting longevity.
- Small molecules targeting protein homeostasis may prevent age-related diseases.
- Further research in C. elegans can inform human healthspan interventions.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients

